Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Cancers
|
October 17, 2019
Topical 2'-Hydroxyflavanone for Cutaneous Melanoma
Chhanda Bose, Sharda P Singh, Henry Igid, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 28, 2024
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes
Luis E Aguirre, Akriti Jain, Somedeb Ball, et al.
Annals of Hematology
|
April 18, 2024
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML
Akriti G Jain, Quinto Gesiotto, Somedeb Ball, et al.
American Journal of Hematology
|
March 9, 2026
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Somedeb Ball, Farrukh T Awan, Ben K Tomlinson, et al.
Haematologica
|
February 1, 2024
Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
Akriti G Jain, Somedeb Ball, Luis Aguirre, et al.
Clinical Hematology International
|
March 30, 2026
Leukemia cutis and all-trans retinoic acid-induced myocarditis in acute promyelocytic leukemia
Kian J Rahbari, Parth C Patel, Sarah Profitt, et al.
Leukemia
|
May 5, 2023
Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes
Luis E Aguirre, Najla Al Ali, David A Sallman, et al.
American Journal of Hematology
|
October 21, 2021
Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms
Amber C King, Taylor M Weis, Andriy Derkach, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 22, 2023
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes
Sara M Tinsley-Vance, Najla Al Ali, Somedeb Ball, et al.
JCO Precision Oncology
|
March 14, 2024
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib
Andrew T Kuykendall, Somedeb Ball, Barbara Mora, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Cancers
|
October 17, 2019
Topical 2'-Hydroxyflavanone for Cutaneous Melanoma
Chhanda Bose, Sharda P Singh, Henry Igid, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 28, 2024
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes
Luis E Aguirre, Akriti Jain, Somedeb Ball, et al.
Annals of Hematology
|
April 18, 2024
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML
Akriti G Jain, Quinto Gesiotto, Somedeb Ball, et al.
American Journal of Hematology
|
March 9, 2026
Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Somedeb Ball, Farrukh T Awan, Ben K Tomlinson, et al.
Haematologica
|
February 1, 2024
Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia
Akriti G Jain, Somedeb Ball, Luis Aguirre, et al.
Clinical Hematology International
|
March 30, 2026
Leukemia cutis and all-trans retinoic acid-induced myocarditis in acute promyelocytic leukemia
Kian J Rahbari, Parth C Patel, Sarah Profitt, et al.
Leukemia
|
May 5, 2023
Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes
Luis E Aguirre, Najla Al Ali, David A Sallman, et al.
American Journal of Hematology
|
October 21, 2021
Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms
Amber C King, Taylor M Weis, Andriy Derkach, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 22, 2023
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes
Sara M Tinsley-Vance, Najla Al Ali, Somedeb Ball, et al.
JCO Precision Oncology
|
March 14, 2024
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib
Andrew T Kuykendall, Somedeb Ball, Barbara Mora, et al.
Page
of 8